Cytogenetic aberrations in primary cell cultures of the ovarian surface epithelium;Aberraciones citogenéticas en cultivos primarios del epitelio superficial del ovario

Investigacion Clinica

Volumn 51, Issue 4, 2010, Pages 541-551

  Chuaire Noack, Lilian ^a   Rondón Lagos, Sandra ^a   Ramírez Corredor, Amparo ^b   Ibáñez Pinilla, Milcíades ^b   Ramírez Clavijo, Sandra ^a  

^a Facultad de Ciencias   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Cell cultures; Chromosomal instability; Chromosome aberrations; Ovarian epithelium; Polyploidy

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CELL CULTURE; CHROMOSOMAL INSTABILITY; CHROMOSOME 11; CHROMOSOME 3; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COLOMBIA; CONTROLLED STUDY; CYTOGENETICS; EPITHELIUM CELL; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; MENOPAUSE; METAPHASE; MONOSOMY; OVARY CELL; POLYPLOIDY; POPULATION; AGE; AGED; ANEUPLOIDY; CELL TRANSFORMATION; COMPARATIVE STUDY; CYTOLOGY; DISEASE PREDISPOSITION; GENETICS; KARYOTYPING; MIDDLE AGED; MITOSIS INDEX; OVARY; OVARY TUMOR; POSTMENOPAUSE; ULTRASTRUCTURE;

AGE FACTORS; AGED; ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; FEMALE; HUMANS; KARYOTYPING; METAPHASE; MIDDLE AGED; MITOTIC INDEX; OVARIAN NEOPLASMS; OVARY; POSTMENOPAUSE;

EID: 79953748532     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Herbst AL. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol 1994; 170:1099-1105.
2. Scully RE. World Health Organization histological classification of tumors. 1999. Berlin: Springer Verlag.
3. Cancer Facts & Figures 2009. In: http://www.cancer.org/ (Last access: august 11 2009).
4. Surveillance, epidemiology and end results: Ovary cancer. In: National Cancer Institute, http://seer.cancer.gov/ (Last access: august 11 2009).
5. Registro Poblacional de Cáncer de Cali, Colombia. Ovario. In: RPPC: Registro Poblacional de Cáncer de Cali, Colombia. http://rpcc.univalle.edu.co/es/index.php. Last date of access: june 13 2010.
6. Bayani J, Paderova J, Murphy J, Rosen B, Zielenska M, Squire JA. Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer. Neoplasia 2008; 10:1057-1065.
7. Mayr D, Diebold J. Chromosomal changes in ovarian cancer. Curr Diagn Pathol 2003; 9:328-332.
8. Mitelman F, Mertens F, Johansson B. Prevalence estimates of recurrent balanced cytogenetics aberrations and gene fusions in unselected patients with neoplastic disorders. Genes Chromosomes Cancer 2005; 43:350-366.
9. Trent JM, Salmon SE. Karyotypic analysis of human ovarian carcinoma cells cloned in short term agar culture. Cancer Genet Cytogenet 1981; 3:279-291
10. Trent JM, Thompson FH, Alberts DS. Recurring sites of chromosome change in human ovarian carcinoma. Cancer Genet Cytogenet 1987; 28:36-40.
11. Barch MJ. The AGT Cytogenetics Laboratory Manual. 3rd Edición. Ed. Turid Knutsen & Jack L. Spurbeck. 1997. Ed. Lippincott-Raven Publishers. pp 401-403.
12. Tibiletti MG, Bernasconi B, Furlan D, Bressan P, Cerutti R, Facco C, Franchi M, Riva C, Cinquetti R, Capella C, Taramelli R. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms. Clin Cancer Res 2001; 7:3404-3409.
13. Thompson FH, Emerson J, Alberts D, Liu Y, Guan XY, Burgess A, Fox S, Taetle R, Weinstein R, Makar R. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 1994; 73:33-45.
14. Micci F, Haugom L, Ahlquist T, Andersen HK, Abeler VM, Davidson B, Trope CG, Lothe RA, Heim S. Genomic aberrations in borderline ovarian tumors J Transl Med 2010; 8:21.
15. Panani AD, Aravidis C, Kosmaidou Z, Rodolakis A, Antsaklis A. Simple structural chromosomal abnormalities in advanced stage of ovarian cancer. In Vivo 2009; 23:425-428.
16. Huang NF, Gupta M, Varghese S, Rao S, Luke S. Detection of numerical chromosomal abnormalities in epithelial ovarian neoplasms by fluorescence in situ hybridization (Fish) and a review of the current literature. Appl Immunohistochem Mol Morphol 2002;10: 187-193.
17. Shayesteh L, Lu Y, Kuo WL Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999; 21:99-102.
18. Høgdall E, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK. P53 mutations in tissue from Danish ovarian cancer patients from the Danish ''MALOVA'' ovarian cancer study. Gynecol Oncol 2006; 100:76-82.
19. McCoy ML, Mueller CR, Roskelley CD. The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reprod Biol Endocrinol 2003; 1:72.
20. Lee-Jones L. Ovarian tumours: an overview. Atlas Genet Cytogenet Oncol Haematol 2003. In: http://AtlasGenetics Oncology.org/Genes/OvarianTumOverview ID5231. html (Last access: august 28 2009).
21. Panani AD, Roussos C. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Letters 2006; 235:30-135.
22. Jancarkova N, Krkavcova M, Janashia M, Freitag P, Duskova J, Cibula D. Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancer. Folia Biol (Praha) 2008; 54:58-64.
23. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biology 2005; 37:961-976.
24. Katakura Y. Molecular basis for the cellular senescence program and its application to anticancer therapy. Biosci Biotechnol Biochem 2006; 70:1076-1081.
25. Campisi J, D'Adda di Fagagna F. Cellular senescence: When bad things happen to good cells. Mol Cell Biol 2007; 8:729-740.
26. Sherwood SW, Rush D, Ellsworth JL, Schimke RT. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci USA 1988; 85:9086e90.
27. Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P. Replicative senescence of human endothelial cells in vitro envolves G1 arrest, polyploidization and. senescence-associated apoptosis. Exp Gerontol 2001; 36:1327-1347.
28. Walen KH. Budded karyoplasts from multinucleated fibroblast cells contain centrosomes and change their morphology to mitotic cells. Cell Biol Int 2005; 29:1057e65.
29. Walen KH. Human diploid fibroblast cells in senescence; cycling through polyploidy to mitotic cells. In Vitro Cell Dev Biol Anim 2006; 42:216-224.
30. Jones MR, Ravid K. Vascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expression. J Biol Chem 2004; 279:5306-5313.
31. Yang D, McCrann DJ, Nguyen H, St. Hilaire C, DePinho RA, Jones MR, Ravid K. Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell 2007; 6:257-260.
32. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguría A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436:642.
33. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. BRAFE600-associated senescence- like cell cycle arrest of human naevi. Nature 2005; 436:720-724.
34. Campisi J. Cancer and ageing: rival demons? Nat Rev Cancer 2003; 3:339.
35. Campisi J. Cellular senescence and apoptosis: How cellular responses might influence ageing phenotypes. Exp Geront 2003; 38:5-11.
36. Atkin NB. Chromosomal doubling: the significance of polyploidization in the development of human tumors: possibly relevant findings on a lymphoma. Cancer Genet Cytogenet 2000; 116:81-83.
37. Margolis RL, Lohez OD, Andreassen PR. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 2003; 88:673-683.
38. Margolis RL. Tetraploidy and tumor development. Cancer Cell 2005; 8:353-354.
39. Guc-Scekic M, Milasin J, Stevanovic M, Stojanov LJ, Djordjevic M. Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies). Clin Genet 2002; 1:62-65.
40. Brodsky WY, Uryvaeva IV. Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol 1977; 50:275-332.
41. Zybina TG, Zybina EV. Cell reproduction and genome multiplication in the proliferative and invasive trophoblast cell populations of mammalian placenta. Cell Biol Int 2005; 29:1071-1083.
42. Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol 2002; 190:7-20.
43. Olaharski A, Sotelo R, Solorza-Luna G, Gonsebatt M, Guzman P, Mohar A, Eastmond D. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 2006; 27:337-343.
44. Barrett MT, Pritchard D, Palanca-Wessel C, Anderson J, Reid BJ. Molecular phenotype of spontaneously arising 4N (G2- tetraploid) intermediates of neoplastic progression in Barrett's esophagus. Cancer Res 2003; 63:4211e7.
45. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999; 9:M57-M60.
46. Greenebaum E, Yee HT, Liu J. DNA ploidy of ovarian and adnexal cyst fluid. A useful adjunct to cytology. Acta Cytol 1994; 38:201-208.
47. Teixeira M, Pandis N, Heim S. Cytogenetic clues to breast carcinogenesis. Genes Chromosomes Cancer 2002; 33:1-16.
48. Pérez E, Roche P, Jenkins R, Reynolds C, Halling K, Ingle J, Wold L. HER2 testing in patients with breast cancer: poor correlation between weak posivity by Immunohistochemistry and gene amplification by fluorescence in situ hybridization Mayo. Clin Proc 2002; 77:148-154.
49. Tanja F, Morrison L, Saboorian H, Hyan L, Tucker T, Uhr J. Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat 2002; 75:227-239.
50. Watter A, Going J, Cooke T, Bartlett J. Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma. Breast Cancer Res Treat 2003; 77:109-114.
51. Wong AS, Auersperg N. Ovarian surface epithelium: family history and early events in ovarian cancer. Reprod Biol Endocrinol 2003; 7:1-70.